H.R. 3082 (119th)Bill Overview

Evidence-Based Drug Policy Act of 2025

Crime and Law Enforcement|Crime and Law Enforcement
Cosponsors
Support
Democratic
Introduced
Apr 29, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determin…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This bill repeals Section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998.

No other language or amendments are included in the text provided.

Passage40/100

Narrow, low-cost repeal improves prospects, but unknown content of the repealed clause and lack of compromise features create material uncertainty.

CredibilityAligned

Relative to its intended legislative type, this bill is a narrowly targeted statutory repeal that is legally precise in identifying the provision to be removed but provides minimal contextual, fiscal, transitional, or oversight detail.

Contention60/100

Liberals view repeal as enabling evidence-based public-health approaches

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Federal agenciesPermitting process · Federal agencies
Likely helped
  • Federal agenciesAllows ONDCP to fund or conduct previously prohibited research, potentially increasing federal public-health research a…
  • Targeted stakeholdersMay reduce regulatory constraints, speeding policy updates and program deployment within ONDCP.
  • Targeted stakeholdersCould improve evidence-based policymaking, potentially leading to more effective prevention and treatment programs.
Likely burdened
  • Permitting processRemoves a statutory safeguard, possibly permitting actions some stakeholders view as endorsing drug policy changes.
  • Federal agenciesCould create legal uncertainty between federal ONDCP actions and state controlled-substance laws.
  • Targeted stakeholdersMay increase regulatory burden for other agencies adjusting to changed ONDCP priorities.
03 · Why people split

Why the argument around this bill splits.

Liberals view repeal as enabling evidence-based public-health approaches
Progressive80%

Likely supportive, viewing repeal as removing a statutory barrier to evidence-based drug treatment, harm reduction, or research.

Support hinges on the repealed subsection having limited such programs; that content is not included in the bill text.

Leans supportive
Centrist55%

Cautiously supportive but conditional: the repeal could promote evidence-based policymaking, but requires clarification on effects, costs, and legal consequences before full endorsement.

Split reaction
Conservative25%

Likely skeptical or opposed, seeing repeal as possibly weakening statutory drug-control measures or confusing enforcement priorities; reaction depends on the unknown content of the repealed subsection.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Narrow, low-cost repeal improves prospects, but unknown content of the repealed clause and lack of compromise features create material uncertainty.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Text of section 704(b)(12) being repealed is not included
  • Whether the repealed language is ideologically or practically controversial
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals view repeal as enabling evidence-based public-health approaches

Narrow, low-cost repeal improves prospects, but unknown content of the repealed clause and lack of compromise features create material unce…

Unlocked analysis

Relative to its intended legislative type, this bill is a narrowly targeted statutory repeal that is legally precise in identifying the provision to be removed but provides minimal contextual, fiscal, transitional, or o…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis